Document is current
Any future updates will be listed below
-
Authors
Krammer, Florian https://orcid.org/0000-0003-4121-776X
- License Information
-
More Information
Article History
Received: 26 January 2023
Accepted: 24 May 2023
First Online: 12 July 2023
Declarations
:
: Florian Krammer has been consulting for Curevac, Seqirus and Merck and is currently consulting for Pfizer, Third Rock Ventures, Avimex, and GSK. He is named on several patents regarding influenza virus and SARS-CoV-2 vaccines, influenza virus therapeutics, and SARS-CoV-2 serological tests. Some of these technologies have been licensed to commercial entities and Dr. Krammer is receiving royalties from these entities. Dr. Krammer is also an advisory board member of Castlevax, a spin-off company formed by the Icahn School of Medicine at Mount Sinai to develop SARS-CoV-2 vaccines. The Krammer laboratory has received funding for research projects from Pfizer, GSK, and Dynavax and three of Dr. Krammer’s mentees have recently joined Moderna.
